Drug Shortage Report for TARO-CLARITHROMYCIN

Last updated on 2024-02-14 History
Report ID 173628
Drug Identification Number 02390442
Brand name TARO-CLARITHROMYCIN
Common or Proper name CLARITHROMYCIN
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) CLARITHROMYCIN
Strength(s) 125MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 55ml
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-12
Estimated end date 2023-05-19
Actual end date 2023-05-19
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2024-02-14 English Compare
v29 2023-06-09 French Compare
v28 2023-06-09 English Compare
v27 2023-04-28 French Compare
v26 2023-04-28 English Compare
v25 2023-04-10 French Compare
v24 2023-04-10 English Compare
v23 2023-03-24 French Compare
v22 2023-03-24 English Compare
v21 2023-03-10 French Compare
v20 2023-03-10 English Compare
v19 2023-02-22 French Compare
v18 2023-02-22 English Compare
v17 2023-02-10 French Compare
v16 2023-02-10 English Compare
v15 2023-02-01 French Compare
v14 2023-02-01 English Compare
v13 2023-01-19 French Compare
v12 2023-01-19 English Compare
v11 2023-01-10 French Compare

Showing 1 to 20 of 30